Antitumorigenic effect of proteasome inhibitors on insulinoma cells.

Détails

ID Serval
serval:BIB_32509
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Antitumorigenic effect of proteasome inhibitors on insulinoma cells.
Périodique
Endocrinology
Auteur⸱e⸱s
Størling J., Allaman-Pillet N., Karlsen A.E., Billestrup N., Bonny C., Mandrup-Poulsen T.
ISSN
0013-7227
Statut éditorial
Publié
Date de publication
2005
Peer-reviewed
Oui
Volume
146
Numéro
4
Pages
1718-1726
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't - Publication Status: ppublish
Résumé
Malignant insulinoma is a critical cancer form with a poor prognosis. Because cure by surgery is infrequent, effective chemotherapy is in demand. Induction of cell death in tumor cells by proteasome inhibitors is emerging as a potential strategy in cancer therapy. Here we investigated whether inhibition of the proteasome has an antitumorigenic potential in insulinoma cells. Exposure of mouse betaTC3 insulinoma cells to the proteasome inhibitor N-Acetyl-Leu-Leu-Nle-CHO (ALLN) reduced cell viability, activated caspase-3, induced apoptosis, and suppressed insulin release. Treatment with ALLN also resulted in phosphorylation of c-jun N-terminal kinase (JNK) and an increase in in vitro phosphorylation of c-jun. In insulinoma cells with impaired JNK signaling, ALLN-induced apoptosis was significantly suppressed. Another proteasome inhibitor, lactacystin, also stimulated JNK activation, caused activation of caspase-3, suppressed cell viability, and induced apoptosis in betaTC3 and rat INS-1E cells. Both ALLN and lactacystin caused a marked decrease in the cellular amount of the JNK scaffold protein JNK-interacting protein 1/islet-brain-1. In primary pancreatic rat islet cells, proteasome inhibition reduced insulin secretion but had no impact on cell viability and even partially protected against the toxic effect of proinflammatory cytokines. Our findings demonstrate that proteasome inhibitors possess antitumorigenic and antiinsulinogenic effects on insulinoma cells.
Mots-clé
Acetylcysteine, Adaptor Proteins, Signal Transducing, Animals, Antineoplastic Agents, Apoptosis, Binding Sites, Cell Line, Tumor, Cysteine Proteinase Inhibitors, Insulinoma, JNK Mitogen-Activated Protein Kinases, Leupeptins, Mice, Pancreatic Neoplasms, Proteasome Endopeptidase Complex, Rats, Signal Transduction, Tumor Suppressor Protein p53
Pubmed
Web of science
Open Access
Oui
Création de la notice
19/11/2007 12:31
Dernière modification de la notice
20/08/2019 13:17
Données d'usage